127 related articles for article (PubMed ID: 12741617)
1. Influence of Eudragit NE 30 D blended with Eudragit L 30 D-55 on the release of phenylpropanolamine hydrochloride from coated pellets.
Zheng W; McGinity JW
Drug Dev Ind Pharm; 2003 Mar; 29(3):357-66. PubMed ID: 12741617
[TBL] [Abstract][Full Text] [Related]
2. Influence of an acrylic polymer blend on the physical stability of film-coated theophylline pellets.
Kucera S; Shah NH; Malick AW; Infeld MH; McGinity JW
AAPS PharmSciTech; 2009; 10(3):864-71. PubMed ID: 19568939
[TBL] [Abstract][Full Text] [Related]
3. pH-Sensitive polymer blends used as coating materials to control drug release from spherical beads: elucidation of the underlying mass transport mechanisms.
Lecomte F; Siepmann J; Walther M; MacRae RJ; Bodmeier R
Pharm Res; 2005 Jul; 22(7):1129-41. PubMed ID: 16028014
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of the stability of venlafaxine hydrochloride sustained-release pellets prepared by double-polymer coatings and hot-melt subcoating combined with Eudragit(®) NE30D outercoating.
Guan T; Wang J; Li G; Tang X
Pharm Dev Technol; 2011 Jun; 16(3):269-77. PubMed ID: 20214529
[TBL] [Abstract][Full Text] [Related]
5. Preparation and in vitro/in vivo evaluation of sustained-release venlafaxine hydrochloride pellets.
Liu Y; Sun Y; Sun J; Zhao N; Sun M; He Z
Int J Pharm; 2012 Apr; 426(1-2):21-28. PubMed ID: 22266529
[TBL] [Abstract][Full Text] [Related]
6. Sustained-release pellets prepared by combination of wax matrices and double-layer coatings for extremely water-soluble drugs.
Tian L; Zhang Y; Tang X
Drug Dev Ind Pharm; 2008 Jun; 34(6):569-76. PubMed ID: 18568906
[TBL] [Abstract][Full Text] [Related]
7. Novel use of Eudragit NE 30D/Eudragit L 30D-55 blends as functional coating materials in time-delayed drug release applications.
El-Malah Y; Nazzal S
Int J Pharm; 2008 Jun; 357(1-2):219-27. PubMed ID: 18353571
[TBL] [Abstract][Full Text] [Related]
8. Drug release mechanisms from Kollicoat SR:Eudragit NE coated pellets.
Cuppok Y; Muschert S; Marucci M; Hjaertstam J; Siepmann F; Axelsson A; Siepmann J
Int J Pharm; 2011 May; 409(1-2):30-7. PubMed ID: 21354465
[TBL] [Abstract][Full Text] [Related]
9. Physicochemical properties of film-coated melt-extruded pellets.
Young CR; Crowley M; Dietzsch C; McGinity JW
J Microencapsul; 2007 Feb; 24(1):57-71. PubMed ID: 17438942
[TBL] [Abstract][Full Text] [Related]
10. Differential scanning calorimetry and surface morphology studies on coated pellets using aqueous dispersions.
Nisar-ur-Rahman ; K H Y; Jia Woei W; Khan NA
Pak J Pharm Sci; 2005 Apr; 18(2):19-23. PubMed ID: 16431393
[TBL] [Abstract][Full Text] [Related]
11. A method for the preparation of sustained release-coated Metoprolol Succinate pellet-containing tablets.
Yang Z; Yu J; Yang T; Xing H; Zhang J; Xian L; Ding P; Wang D
Pharm Dev Technol; 2016 Dec; 21(8):943-950. PubMed ID: 26334840
[TBL] [Abstract][Full Text] [Related]
12. Development of a tamsulosin hydrochloride controlled-release capsule consisting of two different coated pellets.
Zhang X; Tang X; Yang R
Drug Dev Ind Pharm; 2009 Jan; 35(1):26-33. PubMed ID: 18686088
[TBL] [Abstract][Full Text] [Related]
13. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
Sauer D; Zheng W; Coots LB; McGinity JW
Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
[TBL] [Abstract][Full Text] [Related]
14. Evaluating tamsulosin hydrochloride-released microparticles prepared using single-step matrix coating.
Maeda A; Shinoda T; Ito N; Baba K; Oku N; Mizumoto T
Int J Pharm; 2011 Apr; 408(1-2):84-90. PubMed ID: 21291970
[TBL] [Abstract][Full Text] [Related]
15. Preparation and evaluation of nicotinic acid sustained-release pellets combined with immediate release simvastatin.
Zhao X; Li G; Zhang L; Tao X; Guan T; Hong M; Tang X
Int J Pharm; 2010 Nov; 400(1-2):42-8. PubMed ID: 20801201
[TBL] [Abstract][Full Text] [Related]
16. Sustained-release dosage form of phenylpropanolamine hydrochloride. Part I: Microencapsulation and in vitro release kinetics.
Sevgi F; Ozyazici M; Güneri T
J Microencapsul; 1994; 11(3):327-34. PubMed ID: 8064556
[TBL] [Abstract][Full Text] [Related]
17. Preparation and in vitro evaluation of pH, time-based and enzyme-degradable pellets for colonic drug delivery.
Fude C; Lei Y; Jie J; Hongze P; Wenhui L; Dongmei C
Drug Dev Ind Pharm; 2007 Sep; 33(9):999-1007. PubMed ID: 17891587
[TBL] [Abstract][Full Text] [Related]
18. Study of crystallization of endogenous surfactant in Eudragit NE30D-free films and its influence on drug-release properties of controlled-release diphenhydramine HCl pellets coated with Eudragit NE30D.
Lin AY; Muhammad NA; Pope D; Augsburger LL
AAPS PharmSci; 2001; 3(2):E14. PubMed ID: 11741265
[TBL] [Abstract][Full Text] [Related]
19. Preparation and in vitro/in vivo evaluation of sustained-release metformin hydrochloride pellets.
Hu LD; Liu Y; Tang X; Zhang Q
Eur J Pharm Biopharm; 2006 Oct; 64(2):185-92. PubMed ID: 16797948
[TBL] [Abstract][Full Text] [Related]
20. Preparation and bioavailability of sustained-release doxofylline pellets in beagle dogs.
Huang HF; Lu Y; He HB; Tang X
Drug Dev Ind Pharm; 2008 Jul; 34(7):676-82. PubMed ID: 18608467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
